Cumberland Pharmaceuticals Inc. Operating Loss Carryforwards
Cumberland Pharmaceuticals Inc. (CPIX) had Operating Loss Carryforwards of $44.10 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2026-08-07
- 2026-06-30: Operating Loss Carryforwards $44.10M.
- 2026-03-31: Operating Loss Carryforwards $44.10M.
- 2025-09-30: Operating Loss Carryforwards $44.10M.
- 2025-06-30: Operating Loss Carryforwards $44.10M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2026-06-30 | $44.10M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $44.10M 10-Q · filed 2026-05-08 |
| 2025-09-30 | $44.10M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $44.10M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $44.10M 10-Q · filed 2025-05-09 |
| 2024-09-30 | $44.10M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $44.10M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $44.10M 10-Q · filed 2024-05-10 |
| 2023-09-30 | $44.10M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $44.10M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $44.10M 10-Q · filed 2023-05-12 |
| 2022-09-30 | $44.10M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $44.10M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $44.10M 10-Q · filed 2022-05-13 |
| 2021-09-30 | $44.10M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $44.10M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $44.10M 10-Q · filed 2021-05-14 |
| 2020-09-30 | $44.10M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $44.10M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $44.10M 10-Q · filed 2020-05-22 |
| 2019-09-30 | $44.10M 10-Q · filed 2019-11-13 |
| 2017-09-30 | $44.10M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $44.10M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $44.10M 10-Q · filed 2017-05-15 |
| 2016-09-30 | $44.00M 10-Q · filed 2016-11-03 |
| 2012-06-30 | $57.10M 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |